Status:
COMPLETED
Spinal Cord Stimulation in Chemotherapy Induced Neuropathy
Lead Sponsor:
Prisma Health-Upstate
Conditions:
Chemotherapy-induced Peripheral Neuropathy
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational based pilot study evaluating the use of spinal cord stimulators for the treatment of chemotherapy induced peripheral neuropathy will lead to an increase in quality of life and...
Detailed Description
Cancer treatment, for many patients, results in painful side effects. As evidence mounts demonstrating the risks associated with long term opioid therapy, non-opioid modalities need to be developed. S...
Eligibility Criteria
Inclusion
- • The patient has persistent, severe peripheral neuropathy secondary to chemotherapy
Exclusion
- • Refusal to undergo a spinal cord stimulator procedure
Key Trial Info
Start Date :
December 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 3 2022
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03764514
Start Date
December 3 2018
End Date
May 3 2022
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Patewood Memorial Hospital
Greenville, South Carolina, United States, 29615